Prof Marom Bikson discusses his work with Transcranial Direct Current Stimulation
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
Release Date: 05/03/2021
Neural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, host Dr. Ladan Jiracek sits down with Francesco Petrini, co-founder and CEO of SensArs, to discuss how intraneural stimulation could help restore sensation in patients with diabetic neuropathy. Francesco explains how loss of feeling in the feet can lead to unnoticed injuries, chronic wounds, and even amputations - and why rebuilding sensory feedback could dramatically improve quality of life. The conversation explores SensArs’ approach to neuromodulation and what it takes to translate sensory neuroprosthetics into real-world clinical impact. Top...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, host Dr. Ladan Jiracek sits down with Dr. , , whose lab uses intracranial brain recordings to study the biology of human cognition. Ignacio shares how cutting-edge neurotechnology like iEEG can reveal the neural dynamics behind decision-making, risk, memory, and brain states - and how those insights could unlock more targeted neuromodulation therapies for psychiatric disorders such as depression and anxiety. Top 3 Takeaways: Epilepsy patients undergoing seizure monitoring often have 100-200 electrodes implanted in their brains and may...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this solo episode of the Neural Implant Podcast, host Dr. Ladan Jiracek shares the story behind finally completing his PhD at the University of Florida - from the highs of passing his dissertation defense to the long, frustrating, and deeply technical journey of developing liquid crystal polymer (LCP)-based neural implants. I break down why LCP is so promising for long-term implantable devices, how delamination and bonding challenges became the core focus of his dissertation, and what it took to fabricate ultra-thin polymer electrodes approaching “biological invisibility.” I also...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, Paul Goode (Glucotrack) dives into the next wave of continuous glucose monitoring: an active, fully implantable CGM designed to deliver long-term, pacemaker-style reliability without external wearables. We discuss first-in-human progress, why implantables may change diabetes care at home, and a fascinating neural angle—how similar chemistry and form factors could be adapted to epidural glucose sensing and even paired with neural recording electrodes to capture metabolic and neural data together. If you care about closed-loop systems, chronic implants, or bridging...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, I speak with , Co-Founder and CSO of , an Italian neurotech company that is redefining the landscape of brain-computer interfaces. Corticale is pioneering a new generation of minimally invasive, CMOS-based neural implants that can record from thousands of neurons simultaneously—introducing their flagship technology, SiNAPS. Fabio walks us through how SiNAPS achieves single-cell resolution recordings via its 1024-electrode array, enabling high-fidelity access to both action potentials and local field potentials deep within cortical tissue. We...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode of the Neural Implant Podcast, we sit down with , co-founder of , a groundbreaking medical technology company pioneering a new frontier in cancer treatment. By integrating neurotechnology, neurobiology, and machine learning, Coherence is building a platform that doesn't just fight cancer—it manages it in real time. Ben shares how Coherence is moving beyond the traditional "cut, burn, poison" model of oncology, and instead focusing on precision neuromodulation to monitor and control cancer progression—offering hope for 24/7 adaptive treatment with fewer side effects and...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we dive into the world of European intellectual property and medtech innovation with , a German and European Patent Attorney specializing in medical technology at . With a background in mechanical engineering, a Ph.D. in liver dialysis research, and a Master of Laws in European IP law, Christian brings a rare and powerful combination of technical, legal, and clinical insight. We explore how startups and investors should think about IP strategy in Europe, the impact of the new Unified Patent Court (UPC), the nuances between U.S. and EU patent landscapes, and how IP due...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this special episode recorded after the workshop in Barcelona, I talk with and , two of the key organizers behind the . We dive into the vision behind this growing event, which brings together top researchers, engineers, clinicians, and entrepreneurs to explore the cutting edge of implantable medical devices. Nicolas and Antoni share insights on the evolution of AIMD technologies, the role of multidisciplinary collaboration, and how this annual workshop is shaping the next generation of innovators. We also touch on the challenges that startups face in the space—regulatory hurdles, IP...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this episode, we sit down with , Chief Business Officer of , to explore a groundbreaking approach to treating obstructive sleep apnea. Lunosa is developing a self-expanding, injectable neurostimulator that aims to replace invasive facial surgeries with a minimally invasive, high-impact solution — tapping into a $10 billion market. Chad also reflects on his time at , a pioneering neuromodulation company that saw both innovation and controversy. He shares insights from testifying against Stimwave’s former CEO, lessons learned from the company’s collapse, and how those experiences shape...
info_outlineNeural Implant podcast - the people behind Brain-Machine Interface revolutions
In this special on-location episode recorded in Leuven, Belgium, we sit down with the co-founders and technical leaders of — (CEO), (CTO), and (CSO). The team shares their journey developing a high-density, intracortical visual prosthesis aimed at restoring vision for the blind. From developing reliable insertion technology to achieving long-term biocompatibility in nonhuman primate models, ReVision Implant is at the forefront of neurotech innovation. Tune in to hear about their challenges, breakthroughs, and what’s next in the race to cure blindness through brain stimulation. This...
info_outlineMarom Bikson is a Biomedical Engineer. He is a Professor at the City College of New York City and also the co-director of the Neural Engineering Group. Marom has been at the City College of New York for over 15 years. He has a B.Sc in Biomedical Engineering from John Hopkins University and a PhD from Case Western University Cleveland. He cofounded Soterix Medical. Marom's research group studies the effects of electricity on the human body and applies this knowledge toward the development of medical devices and electrical safety guidelines.
In today’s episode, Marom talks about his work with Transcranial Direct Current Stimulation and how it works. He also talks about his work with NC Neuromodulation and Soterix Medical
Top three takeaways:
- Transcranial means, through the cranium. And the thing that you're stimulating is targets inside the cortex. So you're trying to identify targets centrally that you think that you can activate. To lead to different therapeutic outcomes.
- TDCS works by the application of direct electrical current to electrodes placed on the scalp.
- “A lot of times when we think about TDCS, we think about changing the sensitivity. And then the question comes in with a sensitivity to what. Often TDCS is combined with other forms of therapy, like behavioural therapy, or physical therapy
[0:00] Ladan introduces the episode and the guest, Prof Marom Bikson
[1:50] Marom introduces himself and his work
[2:30] Marom discusses the wave of persistent COVID symptoms that are referred to as neuro COVID and talks about some of the work he and his colleagues are doing around it.
[4:50] Marom describes how Transcranial Direct Current Simulation work.
“ transcranial means, through the cranium. And the thing that you're stimulating is targets inside the cortex. So you're trying to identify targets centrally that you think that you can activate. To lead to different therapeutic outcomes.”
[6:00] Marom discusses papers documenting the use of TDCS in different therapeutic areas such as depression and pain.
[7:45] Currently, there is no FDA clearance for TDCS in the US so most of the work now happens in clinical trials.
[10:10] TDCS works by the application of direct electrical current to electrodes placed on the scalp.
[13:40] “A lot of times when we think about TDCS, we think about changing the sensitivity. And then the question comes in with a sensitivity to what. Often TDCS is combined with other forms of therapy, like behavioural therapy, or physical therapy.”
[16:20] Marom talks specifically about his research and some of his breakthroughs.
[20:50] Marom talks about his company, Soterix medical; the background for starting the company and what kind of problems they are solving
[27:40] Marom discusses NYC Neuromodulation which he co-founded.
“NYC neuromodulation has now run. I think about five times the last time was an online version. The two times before that we worked with other organizations, the North American neuromodulation society was partnered for one and neuromodulation of science was partnered for another.”
[33:50] So what are some Big pieces of advice that you would say to other neural engineers?
“ If you're loving what you're doing, then that probably means you're on the right path.”